Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:250-255
© 1996 American Heart Association, Inc.
Articles |
Higher Serum Bilirubin Is Associated With Decreased Risk for Early Familial Coronary Artery Disease
From Cardiovascular Genetics, Department of Internal Medicine, Cardiology Division, University of Utah School of Medicine (P.N.H., L.L.W., S.C.H., R.R.W.); Department of Pathology, University of Utah School of Medicine, Associated Regional and University Pathologists (ARUP) (L.L.W.); Intermountain Health Care and University of Utah School of Medicine (B.C.J.); and Cardiology Division, LDS Hospital, and University of Utah School of Medicine (G.M.V.), Salt Lake City.
Abstract Mildly increased serum bilirubin has recently been suggested as a protective factor, possibly reducing the risk of coronary artery disease (CAD) by acting as an antioxidant. We tested this hypothesis by examining serum bilirubin concentrations and other coronary risk factors in 120 men and 41 women with early familial CAD and 155 control subjects. At screening, both cases and control subjects were 38 to 68 years old. Early familial CAD patients had experienced myocardial infarction, coronary artery bypass grafting, or coronary angioplasty by age 55 years for men and 65 for women and had another sibling similarly affected. The average total serum bilirubin concentration was 8.9±6.1 µmol/L in cases and 12.4±8.1 µmol/L in control subjects (P=.0001 for difference). In univariate analysis stratified by sex, serum bilirubin was strongly and inversely related to CAD risk, with relative odds of 0.4 to 0.1 (relative to the lowest quintile, P=.04 to .00001) in both men and women as bilirubin increased into the upper two quintiles. Multiple logistic regression analysis was performed including age, sex, smoking, body mass index, diabetes, hypertension, plasma measured LDL cholesterol, HDL cholesterol, triglycerides, and serum bilirubin as potential risk factors. Bilirubin entered as an independent protective factor with an odds ratio of 0.25 (P=.0015) for an increase of 17 µmol/L (1 mg/dL). The standardized logistic regression coefficient for bilirubin was -.33 compared with -.34 for HDL, suggesting that the protective effect of bilirubin on CAD risk in the population is comparable to that of HDL cholesterol. A history of cigarette smoking was associated with significantly lower serum bilirubin concentration and appeared to attenuate the protective effect of bilirubin.
Key Words: serum bilirubin • coronary artery disease • risk factors • case-control studies • genetics
This article has been cited by other articles:
 |
|
 |
|
  Y.-H. Chen, L.-Y. Chau, J.-W. Chen, and S.-J. Lin Serum Bilirubin and Ferritin Levels Link Heme Oxygenase-1 Gene Promoter Polymorphism and Susceptibility to Coronary Artery Disease in Diabetic Patients Diabetes Care, August 1, 2008; 31(8): 1615 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rantner, B. Kollerits, M. Anderwald-Stadler, P. Klein-Weigel, I. Gruber, A. Gehringer, M. Haak, M. Schnapka-Kopf, G. Fraedrich, and F. Kronenberg Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC Study Clin. Chem., May 1, 2008; 54(5): 851 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R. Datla, G. J. Dusting, T. A. Mori, C. J. Taylor, K. D. Croft, and F. Jiang Induction of Heme Oxygenase-1 In Vivo Suppresses NADPH Oxidase Derived Oxidative Stress Hypertension, October 1, 2007; 50(4): 636 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Wenzel, M. Oelze, M. Coldewey, M. Hortmann, A. Seeling, U. Hink, H. Mollnau, D. Stalleicken, H. Weiner, J. Lehmann, et al. Heme Oxygenase-1: A Novel Key Player in the Development of Tolerance in Response to Organic Nitrates Arterioscler. Thromb. Vasc. Biol., August 1, 2007; 27(8): 1729 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. van der Bol, R. H.J. Mathijssen, W. J. Loos, L. E. Friberg, R. H.N. van Schaik, M. J.A. de Jonge, A. S.Th. Planting, J. Verweij, A. Sparreboom, and F. A. de Jong Cigarette Smoking and Irinotecan Treatment: Pharmacokinetic Interaction and Effects on Neutropenia J. Clin. Oncol., July 1, 2007; 25(19): 2719 - 2726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-P. Lin, C. J. O'Donnell, J. P. Schwaiger, L. A. Cupples, A. Lingenhel, S. C. Hunt, S. Yang, and F. Kronenberg Association Between the UGT1A1*28 Allele, Bilirubin Levels, and Coronary Heart Disease in the Framingham Heart Study Circulation, October 3, 2006; 114(14): 1476 - 1481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Erdmann, N. Grosser, K. Schipporeit, and H. Schroder The ACE Inhibitory Dipeptide Met-Tyr Diminishes Free Radical Formation in Human Endothelial Cells via Induction of Heme Oxygenase-1 and Ferritin J. Nutr., August 1, 2006; 136(8): 2148 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schroder No Nitric Oxide for HO-1 from Sodium Nitroprusside Mol. Pharmacol., May 1, 2006; 69(5): 1507 - 1509. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Kirkby and C. A. Adin Products of heme oxygenase and their potential therapeutic applications Am J Physiol Renal Physiol, March 1, 2006; 290(3): F563 - F571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Sedlak and S. H. Snyder Messenger Molecules and Cell Death: Therapeutic Implications JAMA, January 4, 2006; 295(1): 81 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Gullu, D. Erdogan, D. Tok, S. Topcu, M. Caliskan, T. Ulus, and H. Muderrisoglu High Serum Bilirubin Concentrations Preserve Coronary Flow Reserve and Coronary Microvascular Functions Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2289 - 2294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schroder New signaling routes for an old drug: lipoxin A4 might mediate heme oxygenase-1 induction by aspirin. Focus on "Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells" Am J Physiol Cell Physiol, September 1, 2005; 289(3): C507 - C508. [Full Text] [PDF]
|
|
|
|
|
|
T. Morita Heme Oxygenase and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2005; 25(9): 1786 - 1795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. N. Hopkins, L. L. Wu, S. C. Hunt, and E. A. Brinton Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease J. Am. Coll. Cardiol., April 5, 2005; 45(7): 1003 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Keshavan, T. L. Deem, S. J. Schwemberger, G. F. Babcock, J. M. Cook-Mills, and S. D. Zucker Unconjugated Bilirubin Inhibits VCAM-1-Mediated Transendothelial Leukocyte Migration J. Immunol., March 15, 2005; 174(6): 3709 - 3718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Abraham, R. Rezzani, L. Rodella, A. Kruger, D. Taller, G. Li Volti, A. I. Goodman, and A. Kappas Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2468 - H2477. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-M. Hu, Y.-H. Chen, M.-T. Chiang, and L.-Y. Chau Heme Oxygenase-1 Inhibits Angiotensin II-Induced Cardiac Hypertrophy In Vitro and In Vivo Circulation, July 20, 2004; 110(3): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Sedlak and S. H. Snyder Bilirubin Benefits: Cellular Protection by a Biliverdin Reductase Antioxidant Cycle Pediatrics, June 1, 2004; 113(6): 1776 - 1782. [Full Text] [PDF]
|
|
|
|
|
|
J. Hokamaki, H. Kawano, M. Yoshimura, H. Soejima, S. Miyamoto, I. Kajiwara, S. Kojima, T. Sakamoto, S. Sugiyama, N. Hirai, et al. Urinary biopyrrins levels are elevated in relation to severity of heart failure J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1880 - 1885. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor Different Faces of the Heme-Heme Oxygenase System in Inflammation Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Schwertner Bilirubin Concentration, UGT1A1*28 Polymorphism, and Coronary Artery Disease Clin. Chem., July 1, 2003; 49(7): 1039 - 1040. [Full Text] [PDF]
|
|
|
|
|
|
G. Endler, A. Hamwi, R. Sunder-Plassmann, M. Exner, T. Vukovich, C. Mannhalter, J. Wojta, K. Huber, and O. Wagner Is Low Serum Bilirubin an Independent Risk Factor for Coronary Artery Disease in Men but Not in Women? Clin. Chem., July 1, 2003; 49(7): 1201 - 1204. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Oberle, A. Abate, N. Grosser, A. Hemmerle, H. J. Vreman, P. A. Dennery, H. T. Schneider, D. Stalleicken, and H. Schroder Endothelial Protection by Pentaerithrityl Trinitrate: Bilirubin and Carbon Monoxide as Possible Mediators Experimental Biology and Medicine, May 1, 2003; 228(5): 529 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Novotny and L. Vitek Inverse Relationship Between Serum Bilirubin and Atherosclerosis in Men: A Meta-Analysis of Published Studies Experimental Biology and Medicine, May 1, 2003; 228(5): 568 - 571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Baranano, M. Rao, C. D. Ferris, and S. H. Snyder From the Cover: Biliverdin reductase: A major physiologic cytoprotectant PNAS, December 10, 2002; 99(25): 16093 - 16098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kaneda, M. Ohno, J. Taguchi, M. Togo, H. Hashimoto, K. Ogasawara, T. Aizawa, N. Ishizaka, and R. Nagai Heme Oxygenase-1 Gene Promoter Polymorphism Is Associated With Coronary Artery Disease in Japanese Patients With Coronary Risk Factors Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1680 - 1685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Durante Carbon monoxide and bile pigments: surprising mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 195 - 202. [Abstract] [PDF]
|
|
|
|
|
|
S. R. Vulapalli, Z. Chen, B. H. L. Chua, T. Wang, and C.-S. Liang Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H688 - H694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. G. V. Hoydonck, E. H. Temme, and E. G Schouten Serum bilirubin concentration in a Belgian population: the association with smoking status and type of cigarettes Int. J. Epidemiol., December 1, 2001; 30(6): 1465 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nakayama, K. Takahashi, T. Komaru, M. Fukuchi, H. Shioiri, K.-i. Sato, T. Kitamuro, K. Shirato, T. Yamaguchi, M. Suematsu, et al. Increased Expression of Heme Oxygenase-1 and Bilirubin Accumulation in Foam Cells of Rabbit Atherosclerotic Lesions Arterioscler. Thromb. Vasc. Biol., August 1, 2001; 21(8): 1373 - 1377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ishizaka, Y. Ishizaka, E. Takahashi, M. Yamakado, and H. Hashimoto High Serum Bilirubin Level Is Inversely Associated With the Presence of Carotid Plaque Stroke, February 1, 2001; 32 (2): 580 - 583. [Full Text] [PDF]
|
|
|
|
|
|
M. Mayer Association of Serum Bilirubin Concentration with Risk of Coronary Artery Disease Clin. Chem., November 1, 2000; 46(11): 1723 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Clark, R. Foresti, P. Sarathchandra, H. Kaur, C. J. Green, and R. Motterlini Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction Am J Physiol Heart Circ Physiol, February 1, 2000; 278(2): H643 - H651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Durante, K. J. Peyton, and A. I. Schafer Platelet-Derived Growth Factor Stimulates Heme Oxygenase-1 Gene Expression and Carbon Monoxide Production in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2666 - 2672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Dore, M. Takahashi, C. D. Ferris, L. D. Hester, D. Guastella, and S. H. Snyder Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury PNAS, March 2, 1999; 96(5): 2445 - 2450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. C.M. Siow, H. Sato, and G. E. Mann Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide? Cardiovasc Res, February 1, 1999; 41(2): 385 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N. Hopkins, L. L. Wu, S. C. Hunt, B. C. James, G. M. Vincent, and R. R. Williams Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2783 - 2792. [Abstract] [Full Text]
|
|
|
|
|
|
S. C. Hunt, L. L. Wu, P. N. Hopkins, and R. R. Williams Evidence for a Major Gene Elevating Serum Bilirubin Concentration in Utah Pedigrees Arterioscler. Thromb. Vasc. Biol., August 1, 1996; 16(8): 912 - 917. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Salim, B. A. Brown-Kipphut, and M. D. Maines Human Biliverdin Reductase Is Autophosphorylated, and Phosphorylation Is Required for Bilirubin Formation J. Biol. Chem., March 30, 2001; 276(14): 10929 - 10934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-F. Yet, R. Tian, M. D. Layne, Z. Y. Wang, K. Maemura, M. Solovyeva, B. Ith, L. G. Melo, L. Zhang, J. S. Ingwall, et al. Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice Circ. Res., July 20, 2001; 89(2): 168 - 173. [Abstract] [Full Text] [PDF]
|
|